Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HTA trials will no longer infringe UK patent law

This article was originally published in Scrip

Executive Summary

A legal obstacle to the conduct of clinical trials in the UK should be removed by October 1, if recommendations from the UK government are followed. The UK’s narrow interpretation of the research exceptions to the 1977 UK Patents Act had meant that companies conducting comparative clinical research in the UK were open to prosecution for patent infringement. The government has now recommended a broader interpretation of the exceptions that aligns the UK with other major European nations and, according to industry associations, promises to make the UK a more attractive venue for comparative trials.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC020530

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel